Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elektro-Emanuel AB. The company carries out electrical installations for both companies and private individuals and has offices in four cities in western Sweden.
Moleculent AB, a company pioneering technology to study the communication between cells in human tissue, has closed its oversubscribed $26 million Series A financing. The round was led by ARCH Venture Partners and co-led by Eir Ventures with participation from the company’s existing investors.
Vinge, together with Thommessen, advised the infrastructure group Eleda in connection with the acquisition of Sartor & Drange AS, a market-leading civil engineering contractor in the Bergen region. Sartor & Drange AS offers services in areas such as road, water and sewerage and foundation work in Western Norway. Sartor & Drange AS has approximately 200 employees and a turnover of approximately NOK 1,100 million.
Vinge has advised Svea Bank AB in connection with its issuance of SEK 300 million callable tier 2 capital bonds (T2) with a floating rate interest of 3-month STIBOR + 6.75%. The issue date is set to 7 June 2024, and the bonds have a maturity of 10.25 years with first permitted redemption date after 5 years. The instruments will be listed on Nasdaq Stockholm.
Vinge has advised Axcel VII (“Axcel”) and XPartners Samhällsbyggnad (”XPartners”) in connection with the acquisition of HTJ Holding OY and its subsidiary Rakennuttajatoimisto HTJ Oy (”HTJ”).
The energy storage facility Bredhälla consists of batteries utilizing lithium-ion technology with a total capacity of 42,5MW /42,5MWh spread across 20 modules, making it the largest battery park in Sweden. Bredhälla will provide ancillary services to Svenska Kraftnät to ensure stability in the electricity grid and participate in wholesale markets by providing energy arbitrage.
Vinge has advised Doconomy AB, a fintech start-up that provides banks with resources to promote financial health and climate action, in connection with its EUR 34 million Series B funding round. The round was led by UBS Next, the VC and innovation arm of UBS, and existing investor CommerzVentures, which acted as co-lead. Other shareholders who participated in the round include Motive Ventures, PostFinance and Tenity.
Priveq, a leading Nordic lower mid-market growth and buyout investor, has closed its seventh fund, Priveq Investment VII, at SEK 3 billion. The fund’s first and final closing was significantly oversubscribed with strong backing from existing investors and substantial interest from new institutional investors.
On 28 May 2024, Asahi Kasei Corporation announced a public takeover offer to the shareholders and holders of American Depositary Shares in Calliditas Therapeutics AB (publ) (”Calliditas Therapeutics”) to acquire all shares and American Depositary Shares (each representing two shares) in Calliditas Therapeutics.
Vinge advises Axcel V in connection with the sale of Loopia Group to team.blue, Europe’s leading digital enabler for entrepreneurs and SMBs and backed by Hg, a leading investor in European and transatlantic software and services businesses.
